DocSym
β
Searchsearch
Search
(K75.2) Nonspecific reactive hepatitis
More details coming soon
644 190 in individuals diagnosis nonspecific reactive hepatitis confirmed
33 060 deaths with diagnosis nonspecific reactive hepatitis
5% mortality rate associated with the disease nonspecific reactive hepatitis
Diagnosis nonspecific reactive hepatitis is diagnosed Men are 3.77% more likely than Women
334 243
Men receive the diagnosis nonspecific reactive hepatitis
15 017 (4.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
309 947
Women receive the diagnosis nonspecific reactive hepatitis
18 043 (5.8 %)Died from this diagnosis.
Risk Group for the Disease nonspecific reactive hepatitis - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features nonspecific reactive hepatitis
Absence or low individual and public risk
Nonspecific reactive hepatitis - what does this mean
Nonspecific reactive hepatitis is an inflammatory condition of the liver caused by a variety of environmental and infectious agents. it is usually caused by a viral or bacterial infection, drug reaction, or exposure to toxins. it can also be caused by autoimmune diseases, metabolic disorders, or other medical conditions. symptoms include fatigue, jaundice, abdominal pain, and loss of appetite.
What happens during the disease - nonspecific reactive hepatitis
Nonspecific reactive hepatitis is an inflammatory process of the liver which is caused by an underlying disorder or condition such as infection, drug-induced liver injury, or autoimmune disease. it is characterized by an influx of inflammatory cells into the liver, leading to liver cell damage and an increase in liver enzymes. this inflammatory process can cause symptoms such as jaundice, abdominal pain, fatigue, and anorexia.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Blood tests: Complete Blood Count (CBC), Liver Function Tests (LFTs), and Hepatitis Serology
- Imaging tests: Ultrasound, Computerized Tomography (CT) scan, Magnetic Resonance Imaging (MRI)
- Liver biopsy
- Stool sample test
- Urine sample test
Treatment and Medical Assistance
Main goal of the treatment: Reduce inflammation and promote healing of the liver.
- Prescribe medications to reduce inflammation (e.g. corticosteroids)
- Prescribe medications to reduce symptoms (e.g. pain relievers)
- Prescribe medications to reduce the risk of complications (e.g. antiviral drugs)
- Monitor liver enzymes regularly
- Encourage a healthy lifestyle (e.g. exercise, healthy diet)
- Provide lifestyle advice (e.g. avoid alcohol, smoking)
- Provide emotional support
- Refer to specialist for further evaluation
19 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Nonspecific reactive hepatitis - Prevention
Nonspecific reactive hepatitis can be prevented by practicing good hygiene, avoiding contact with contaminated food and water, and getting vaccinated against hepatitis a and b. additionally, it is important to abstain from alcohol and drug use, as these can increase the risk of developing this condition.